CSURGSU Stock View

Centenial Surgical Suture Ltd
stock-view-header

icon 7.85 | 9.58
Market Cap ₹( Cr.)
298.98
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)

Stock View

Last Updated On.
17-Sep-2023
 

The average score for Centenial Surgical Suture Ltd stands at 3 against 4, three months back.

Centenial Surgical Suture Limited is an India-based medical device company engaged in the development, manufacturing, and supply of medical devices. The Company operates through the Medical Devices segment. The Company's products include atraumatic needles and sutures (absorbable and non-absorbable) and cardio blades. Its absorbable sutures consist of natural sutures and synthetic sutures, where natural sutures include Centenial-Catgut Plain, and Centenial-Catgut Chromic, and synthetic sutures include Centicryl Braided, Centicryl Rapid, Monosynth and Centisorb. Its non-absorbable sutures include Centilene, Centlon, Centsilk, Centibond, Centsteel and Centipace. Its medical devices include T-SUIT, Centilene Mesh, Skin Stapler, Centiclip, Aortic Punch and Kinfe. It supplies technical specifications, including tables of dimensions and strength values, as well as chemicals and dye stuffs used in manufacturing each suture material.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
80.44
100 DMA(₹)
73.79
200 DMA(₹)
65.69
52 Weeks Range
46.70     94.48

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required